Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024 [0.03%]
儿童晚发型庞贝病酶替代治疗的启动、转换和停止(SSS)标准：欧洲庞贝病联盟推荐意见(2024年更新)
Benedikt Schoser,Nadine A M E van der Beek,Alexander Broomfield et al.
Benedikt Schoser et al.
Background and purpose: Two novel enzyme replacement therapies (ERTs), studied in phase 3 trials in late-onset Pompe patients, reached marketing authorization by the European Medicines Agency in 2022 and 2023. The Europea...
Wolfgang Grisold
Wolfgang Grisold
Background and purpose: To acknowledge the occasion of the 10th anniversary of the formation of the European Academy of Neurology (EAN), the World Federation of Neurology was invited to contribute its perspective on the f...
A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis [0.03%]
视神经脊髓炎谱系疾病、多发性硬化和少突胶质细胞糖蛋白相关疾病的患者下丘脑受累的比较研究
Wenjing Luo,Xiaonan Zhong,Shishi Shen et al.
Wenjing Luo et al.
Background and purpose: We aimed to characterize hypothalamic involvement in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and compare it with neuromyelitis optica spectrum disorder (NMOSD) and m...
Scoping review of clinical decision support systems for multiple sclerosis management: Leveraging information technology and massive health data [0.03%]
用于管理多发性硬化的临床决策支持系统的综述：利用信息技术和海量健康数据
Stanislas Demuth,Chadia Ed-Driouch,Cédric Dumas et al.
Stanislas Demuth et al.
Background and purpose: Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system, with numerous therapeutic options, but a lack of biomarkers to support a mechanistic approach to precision med...
Corrigendum to Cross-sectional area reference values for peripheral nerve ultrasound in adults: A systematic review and meta-analysis-Part I: Upper extremity nerves [0.03%]
成人周围神经超声参考值的系统评价和meta分析（第一部分）：上肢周围神经——勘误
Published Erratum
European journal of neurology. 2024 Jun 11:e16373. DOI:10.1111/ene.16373 2024
Mobile digital gait analysis captures effects of botulinum toxin in hereditary spastic paraplegia [0.03%]
手机数字化步态分析捕捉肉毒杆菌素在遗传性痉挛性截瘫中的作用
Alzhraa A Ibrahim,Malte Ollenschläger,Stephan Klebe et al.
Alzhraa A Ibrahim et al.
Background and purpose: Hereditary spastic paraplegias (HSPs) comprise a group of inherited neurodegenerative disorders characterized by progressive spasticity and weakness. Botulinum toxin has been approved for lower lim...
Observational Study
European journal of neurology. 2024 Aug;31(8):e16367. DOI:10.1111/ene.16367 2024
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study [0.03%]
血清神经丝轻链在肌萎缩侧索硬化不同表型中的变化：一项纵向多中心研究
Thomas Meyer,Marie Dreger,Torsten Grehl et al.
Thomas Meyer et al.
Objective: To assess the performance of serum neurofilament light chain (sNfL) in clinical phenotypes of amyotrophic lateral sclerosis (ALS). Methods: ...
Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis [0.03%]
载脂蛋白E基因型和脑脊液Aβ及tau生物标志物与肌萎缩侧索硬化认知和运动表型的关联性研究
Alessio Maranzano,Federico Verde,Antonella Dubini et al.
Alessio Maranzano et al.
Objective: Little is known about amyotrophic lateral sclerosis (ALS)-nonspecific cognitive deficits - most notably memory disturbance - and their biological underpinnings. We investigated the associations of the Alzheimer...
Cognitive deficits and cortical volume loss in COVID-19-related hyposmia [0.03%]
COVID-19相关嗅觉减退的认知功能缺损和大脑皮层体积损失
Haşim Gezegen,Ulaş Ay,Bedia Samancı et al.
Haşim Gezegen et al.
Background and purpose: Studies have found that up to 73% of COVID-19 patients experience hyposmia. It is unclear if the loss of smell in COVID-19 is due to damage to the peripheral or central mechanisms. This study aimed...